SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)

• Jaume Capdevila Castillón ^[7] ; Teresa Alonso Gordoa ^[1] ; Alberto Carmona Bayonas ^[8] ; Ana Custodio Carretero ^[2] ; Rocío García-Carbonero ^[3] ; Enrique Grande Pulido ^[9] ; Paula Jiménez Fonseca ^[4] ; Angela Lamarca Lete ^[5] ; Angel Segura Huerta ^[10] ; Javier Gallego Plazas ^[6]
  1. [1] Hospital Ramón y Cajal

     Hospital Ramón y Cajal

     Madrid, España

     
  2. [2] Hospital Universitario La Paz

     Hospital Universitario La Paz

     Madrid, España

     
  3. [3] Hospital Universitario 12 de Octubre

     Hospital Universitario 12 de Octubre

     Madrid, España

     
  4. [4] Hospital Universitario Central de Asturias

     Hospital Universitario Central de Asturias

     Oviedo, España

     
  5. [5] Fundación Jiménez Díaz

     Fundación Jiménez Díaz

     Madrid, España

     
  6. [6] Hospital General Universitario de Elche

     Hospital General Universitario de Elche

     Elche, España

     
  7. [7] Servicio de Oncología Médica, Hospital Universitario Vall D’Hebron, Ps Vall d’Hebron, 119-129, 08035, Barcelona, España
  8. [8] Servicio de Oncología Médica, Hospital Universitario Morales Meseguer, Murcia, España
  9. [9] Servicio de Oncología Médica, MD Anderson Cancer Center, Madrid, España
  10. [10] Servicio de Oncología Médica, Hospital Universitari i Politècnic la Fe, Valencia, España

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 25, Nº. 9 (September), 2023, págs. 2692-2706
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Neuroendocrine neoplasms (NENs) are a heterogeneous family of tumors of challenging diagnosis and clinical management. Their incidence and prevalence continue to rise mainly due to an improvement on diagnostic techniques and awareness. Earlier detection, along with steadfast improvements in therapy, has led to better prognosis over time for advanced gastrointestinal and pancreatic neuroendocrine tumors. The aim of this guideline is to update evidence-based recommendations for the diagnosis and treatment of gastroenteropancreatic and lung NENs. Diagnostic procedures, histological classification, and therapeutic options, including surgery, liver-directed therapy, peptide receptor radionuclide therapy, and systemic hormonal, cytotoxic or targeted therapy, are reviewed and discussed, and treatment algorithms to guide therapeutic decisions are provided.